Dexmedetomidine and Hypoxic Pulmonary Vasoconstriction in Thoracic Surgical Procedures and One-Lung Ventilation
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of Dexmedetomidine when used during
thoracic surgery.
The primary outcome will be changes in oxygenation as measured the PaO2 during one lung
ventilation.
Details
Lead Sponsor:
University of Missouri-Columbia
Collaborators:
Hospira, Inc. Hospira, now a wholly owned subsidiary of Pfizer